193.2 📚 國考版

193.2.0.1 必背 — RIPE Drugs (Ch 192 detail)

• Rifampin + Isoniazid + Pyrazinamide + Ethambutol

193.2.0.2 必背 — Standard 6-Month Regimen

• 2HRZE / 4HR (intensive 2 mo + continuation 4 mo)

193.2.0.3 必背 — 2024 WHO 4-Month Regimen

• For drug-sensitive non-cavitary smear-neg
• Rifapentine + Moxifloxacin + INH + PZA

193.2.0.4 必背 — BPaL / BPaLM

• MDR / Pre-XDR / XDR × 6 months
• 2024 WHO first-line

193.2.0.5 必背 — TB Meningitis

• 9-12 mo + steroid (dexamethasone)
• High mortality without prompt Tx

193.2.0.6 必背 — IGRA vs TST for LTBI

• IGRA preferred (no BCG cross-reactivity, single visit)

193.2.0.7 必背 — GeneXpert MTB/RIF

• Rapid TB + rifampin R detection (1-2 hr)
• WHO first-line replacing smear

193.2.0.8 必背 — HIV + TB

• ART start within 2-8 wk
• Drug interactions (rifampin)
• IRIS risk in CNS TB

193.2.0.9 必背 — LTBI 3HP

• INH + rifapentine weekly × 12 wk
• Preferred in 2024 (best completion)

---